CN Stock MarketDetailed Quotes
603590 Beijing Konruns Pharmaceutical
- 22.46
- -0.11-0.49%
Market Closed Jan 9 15:00 CST
3.58BMarket Cap31.19P/E (TTM)
22.99High22.30Low8.85KlotVolume22.61Open22.57Pre Close19.97MTurnover0.56%Turnover Ratio23.79P/E (Static)159.36MShares35.6952wk High1.12P/B3.53BFloat Cap20.0752wk Low24.83Limit Up157.24MShs Float55.83Historical High20.31Limit Down3.06%Amplitude20.07Historical Low0.30Dividend TTM22.58Avg Price5.57KlotAsk1.34%Div YieldTTM100Lot Size3.10KlotBid
Beijing Konruns Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -10.08%642.81M | -4.09%414.24M | 11.24%219.08M | 12.76%949.73M | 12.18%714.9M | 8.35%431.89M | -12.44%196.95M | 1.37%842.28M | 16.63%637.28M | 3.42%398.61M |
| Refunds of taxes and levies | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.3M | ---- | ---- |
| Cash received relating to other operating activities | 4.72%31.88M | -0.63%25.65M | -73.72%4.37M | -27.30%32.59M | -12.77%30.44M | -2.82%25.82M | 61.31%16.63M | -59.24%44.83M | -59.06%34.89M | -60.69%26.56M |
| Cash inflows from operating activities | -9.48%674.68M | -3.89%439.9M | 4.62%223.45M | 10.57%982.32M | 10.88%745.34M | 7.65%457.7M | -9.21%213.58M | -5.58%888.4M | 6.42%672.18M | -6.14%425.17M |
| Goods services cash paid | -14.61%58.1M | 1.17%44.9M | -29.81%13.95M | 25.87%89.39M | 24.28%68.04M | 47.44%44.38M | 44.30%19.87M | -1.10%71.01M | 19.04%54.75M | 11.81%30.1M |
| Staff behalf paid | 22.82%163.26M | 19.86%110.13M | 23.43%60.25M | 5.87%175.01M | 7.12%132.93M | 5.84%91.88M | -0.97%48.81M | 6.09%165.3M | 6.23%124.1M | 9.18%86.81M |
| All taxes paid | -20.52%19.21M | -22.30%12.34M | -33.52%10.45M | 10.51%51.86M | -27.99%24.16M | -44.71%15.89M | 33.93%15.72M | -34.65%46.92M | -43.67%33.56M | -38.10%28.73M |
| Cash paid relating to other operating activities | -13.76%322.4M | -27.22%190.4M | -17.94%93.78M | -3.86%466.72M | 13.93%373.82M | 22.66%261.61M | 10.67%114.28M | -14.91%485.47M | -22.32%328.1M | -35.32%213.27M |
| Cash outflows from operating activities | -6.01%562.97M | -13.53%357.78M | -10.20%178.42M | 1.85%782.97M | 10.81%598.95M | 15.28%413.76M | 11.58%198.68M | -11.64%768.71M | -16.17%540.51M | -25.63%358.92M |
| Net cash flows from operating activities | -23.69%111.72M | 86.86%82.12M | 202.24%45.03M | 66.56%199.35M | 11.18%146.39M | -33.67%43.95M | -73.95%14.9M | 68.79%119.69M | 1,104.59%131.67M | 323.95%66.25M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -8.48%950.76M | -33.25%599.26M | -56.06%249.26M | 250.73%1.33B | 448.56%1.04B | 374.11%897.83M | 4,768.39%567.33M | -34.10%378.87M | -64.64%189.37M | -60.51%189.37M |
| Cash received from returns on investments | 4.24%13.35M | 6.06%11.92M | -79.48%364.04K | 77.49%14.97M | 58.25%12.81M | 38.91%11.24M | 2,370.35%1.77M | -14.57%8.44M | -14.19%8.09M | -14.19%8.09M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 1,623.75%27.58K | ---- | ---- | 2,820.00%14.6K | 220.00%1.6K | ---- | ---- | -98.90%500 | -96.68%500 | -96.68%500 |
| Cash received relating to other investing activities | ---- | ---- | ---- | -82.10%2.73M | --2.73M | --2.73M | --2.73M | --15.23M | ---- | ---- |
| Cash inflows from investing activities | -8.56%964.14M | -32.97%611.19M | -56.35%249.63M | 234.51%1.35B | 433.95%1.05B | 361.75%911.8M | 4,776.74%571.83M | -31.17%402.54M | -63.77%197.47M | -59.62%197.47M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 29.55%66.66M | 19.68%29.56M | 22.81%15.12M | 4.78%100.91M | -35.58%51.46M | -66.88%24.7M | -43.28%12.31M | -41.51%96.31M | -23.32%79.88M | 52.56%74.6M |
| Cash paid to acquire investments | -27.22%930M | -48.65%610M | -67.52%220M | 168.47%1.69B | 380.87%1.28B | 575.94%1.19B | 545.09%677.35M | -8.32%630.73M | -36.50%265.73M | -54.73%175.73M |
| Cash outflows from investing activities | -25.02%996.66M | -47.25%639.56M | -65.91%235.12M | 146.79%1.79B | 284.62%1.33B | 384.37%1.21B | 444.29%689.66M | -40.76%727.04M | -60.84%345.61M | -42.73%250.33M |
| Net cash flows from investing activities | 88.17%-32.52M | 90.56%-28.38M | 112.31%14.5M | -37.97%-447.72M | -85.59%-274.94M | -468.88%-300.75M | -2.47%-117.83M | 49.49%-324.51M | 56.12%-148.15M | -201.86%-52.87M |
| Financing cash flow | ||||||||||
| Cash from borrowing | 17.49%160.71M | -29.92%76.01M | -44.40%44.04M | --147.76M | --136.78M | --108.46M | --79.2M | ---- | ---- | ---- |
| Cash received relating to other financing activities | -77.16%9.68M | ---- | ---- | --42.4M | --42.4M | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | -4.91%170.4M | -29.92%76.01M | -44.40%44.04M | --190.16M | --179.19M | --108.46M | --79.2M | ---- | ---- | ---- |
| Borrowing repayment | 5,116.71%108.53M | 17,901.35%71.36M | --15.91M | --2.08M | --2.08M | --396.41K | ---- | ---- | ---- | ---- |
| Dividend interest payment | 56.23%51.88M | 741.51%2.68M | 224.68%1.34M | -25.56%34.95M | -29.27%33.21M | -99.32%318.04K | --414.22K | -15.57%46.95M | -15.60%46.95M | -15.38%46.95M |
| Cash payments relating to other financing activities | -3.39%6.12M | -21.02%3.64M | -22.39%1.69M | -4.37%9.51M | -32.27%6.33M | 25.50%4.61M | -1.24%2.18M | -96.17%9.94M | -92.78%9.35M | -96.43%3.67M |
| Cash outflows from financing activities | 300.13%166.52M | 1,358.77%77.68M | 630.33%18.95M | -18.20%46.54M | -26.07%41.62M | -89.48%5.32M | 17.52%2.59M | -83.38%56.89M | -73.51%56.29M | -68.04%50.62M |
| Net cash flows from financing activities | -97.18%3.88M | -101.62%-1.67M | -67.25%25.08M | 352.44%143.62M | 344.38%137.57M | 303.73%103.13M | 3,569.29%76.6M | -198.50%-56.89M | -129.59%-56.29M | 66.48%-50.62M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -232.65%-2.53M | -312.41%-1.95M | -78.95%-622K | -81.78%-1.37M | -517.48%-760.26K | -32.02%-473.94K | -194.81%-347.59K | -389.23%-751.99K | 49.53%-123.12K | -585.08%-359K |
| Net increase in cash and cash equivalents | 874.58%80.54M | 132.51%50.11M | 414.91%84M | 59.57%-106.11M | 111.34%8.26M | -310.05%-154.15M | 55.63%-26.67M | 48.93%-262.46M | 54.64%-72.89M | 70.80%-37.59M |
| Add:Begin period cash and cash equivalents | -31.83%227.22M | -31.83%227.22M | -31.83%227.22M | -44.05%333.33M | -44.05%333.33M | -44.05%333.33M | -62.40%333.33M | -46.31%595.79M | -46.31%595.79M | -46.31%595.79M |
| End period cash equivalent | -9.90%307.76M | 54.78%277.33M | 1.49%311.22M | -31.83%227.22M | -34.67%341.59M | -67.90%179.18M | -62.89%306.65M | -44.05%333.33M | -44.90%522.9M | -43.10%558.2M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
